Myoblast therapy: from bench to bedside (Q36660989)

15 August 2017

1 reference

title

Myoblast therapy: from bench to bedside (English)

1 reference

15 August 2017

0 references

Zhongmin Liu

1

1 reference

15 August 2017

Yanling Wu

series ordinal

2

1 reference

15 August 2017

Bing-guan Chen

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

15

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

455-462

1 reference

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

A New Immunodeficient Mouse Model for Human Myoblast Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Extended Amplification In Vitro and Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast-mediated gene transfer to the joint

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast transfer of human erythropoietin gene in a mouse model of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Cellular and molecular reactions in mouse muscles after myoblast implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

21 January 2018

Regenerating the heart

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Engineering vascularized skeletal muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast transfer in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Skeletal myoblast for cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Development of approaches to improve cell survival in myoblast transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

A self-immunomodulating myoblast cell line for erythropoietin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Problems and solutions in myoblast transfer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Myoblast transplantation for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

Factors affecting functional outcome after autologous skeletal myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981710

10.3727/000000006783981710

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference